Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 277 No 7483 p701
22/29 December 2007

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Shorter MUR form will aid communication with GPs

New design for MUR form

New design was informed by feedback

Communication between GPs and pharmacists about medicines use reviews should be improved following the launch of a new MUR form for use in England.

The form has been reduced to two A4 sheets and only the first overview page of the form need now be sent to GPs and only when action is required.

Alastair Buxton, head of NHS services at the Pharmaceutical Services Negotiating Committee, said: “This new form will streamline the MUR process for pharmacists and enable more efficient communication with patients’ GPs. I hope the new form … will help more pharmacists to conduct more MURs, so that a greater number of patients can benefit.”

New rules approved by the Secretary of State for Health remove the requirement for contractors to send a copy of the MUR form to the GP when no action is required (unless the GP requests they do so). Where a copy of the new form is not sent to the GP, the contractor must notify the GP within one month that an MUR has been conducted.

The new design was informed by feedback from pharmacists, GPs, local pharmaceutical committees and primary care trusts. Changes include moving the action plan and next steps section to the front and adding clinical codes for recording on GP systems.

Mr Buxton pointed out that the launch of the new form provides an opportunity for pharmacists to review how they are providing MURs. “It is important that everybody remembers that the MUR is about the use of medicines, not conducting a clinical review.”

The PSNC reminded contractors that MURs aim to improve patients’ understanding of their medicines, highlight side effects and propose solutions where appropriate, improve adherence to prescribed regimens and reduce medicines wastage. MURs are not a full clinical review or an agreement about changes to medicines.

They should not involve discussions about the effectiveness of medicines based on test results or about the patient’s medical condition beyond that needed to improve their understanding of the use of their medicines.

Contractors can start to use the new form immediately. The original version can be used until 30 September 2008, but the full form will need to be sent to the GP.

The new version of the form can be downloaded from the PSNC website and a photocopy template will be published in the January 2008 issue of PSNC Community Pharmacy News. The PSNC said that updated triplicate pads of the form should be available soon and that pharmacy software suppliers will update their patient medication record systems to include the new form as quickly as possible.

MURs in Wales Pharmacy contractors in Wales should continue to use the original version of the form until the Welsh Assembly Government approves the new version and amends the Welsh Directions. Further guidance will be issued by Community Pharmacy Wales in due course.

Back to Top


©The Pharmaceutical Journal